(NASDAQ: KMDA) Kamada's forecast annual revenue growth rate of 17.06% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 3,625.67%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 1,472.57%.
Kamada's revenue in 2025 is $174,787,000.On average, 5 Wall Street analysts forecast KMDA's revenue for 2026 to be $11,766,104,393, with the lowest KMDA revenue forecast at $11,174,952,674, and the highest KMDA revenue forecast at $12,280,774,420.
In 2027, KMDA is forecast to generate $12,692,510,442 in revenue, with the lowest revenue forecast at $11,851,211,839 and the highest revenue forecast at $13,267,560,752.